Financial News

Recent Quotes
My Watchlist
Indicators
Motherlode Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Geron Corp (NQ: GERN )

1.670 USD -0.025 (-1.47%)
Streaming Delayed Price Updated: 10:06 AM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Geron Corp

< Previous 1 2 3 4 5 6 7 8 9
...
67 68 Next >
Geron to Present at the B. Riley Securities Virtual Oncology Investor Conference
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Chairman and Chief Executive Officer, will present a company overview at... 
From Business Wire News Releases
Interesting GERN Call Options For February 2021
Investors in Geron Corp. (GERN) saw new options begin trading this week, for the February 2021 expiration.. 
Tags Stocks
From Market News Video
Geron Announces Opening of IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced the opening for patient screening and enrollment of the IMpactMF Phase 3 clinical trial of imetelstat,... 
From Business Wire News Releases
Geron Announces Fifty Percent Enrollment Milestone in IMerge Phase 3 Clinical Trial in Lower Risk MDS
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced achievement of fifty percent enrollment in the IMerge Phase 3 clinical trial of imetelstat in lower... 
From Business Wire News Releases
Geron Reports Ten Imetelstat Presentations at American Society of Hematology Annual Meeting
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that four oral presentations and six poster presentations containing clinical data and analyses... 
From Business Wire News Releases
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Geron Corporation (Nasdaq: GERN) today reported that it has granted a non-statutory stock option to purchase an aggregate of 80,000 shares of Geron common stock as an inducement to a newly-hired... 
From Business Wire News Releases
12 Healthcare Stocks Moving In Tuesday's After-Market Session
Gainers Varex Imaging (NASDAQ:VREX) stock rose 7.36% to $15.6 during Tuesday's after-market session. Trading volume for this ... 
Tags Market News MGEN VREX
From Benzinga
Geron to Present at the Stifel Virtual Healthcare Conference
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Chairman and Chief Executive Officer, will present a company overview at... 
From Business Wire News Releases
Recap: Geron Q3 Earnings
Shares of Geron (NASDAQ:GERN) remained unaffected after the company reported Q3 results. Quarterly Results Earnings per share ... 
Tags Earnings Benzinga Market News
From Benzinga
Geron Corporation Reports Third Quarter 2020 Financial Results and Current Events
From GlobeNewswire News Releases
The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags RMD Earnings NBRV
From Benzinga
Geron Announces Ten Imetelstat Presentations at Upcoming American Society of Hematology Annual Meeting
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that ten abstracts containing clinical data and analyses related to imetelstat, the Company’s... 
From Business Wire News Releases
The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings
Biotech stocks continued to sway to the tunes of the broader market in the week ended Oct. 30, which succumbed to geopolitical and ... 
Tags ISEE HALO ABUS
From Benzinga
Geron to Announce Third Quarter Financial Results on November 5, 2020
Geron Corporation (Nasdaq: GERN) today announced that it will release its third quarter 2020 financial results after the market closes on Thursday, November 5, 2020 via press release, which will be... 
From Business Wire News Releases
Geron Announces Publication of IMerge Phase 2 Data in Journal of Clinical Oncology
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that data from the IMerge Phase 2 trial were published in the Journal of Clinical Oncology. The... 
From Business Wire News Releases
12 Healthcare Stocks Moving In Friday's After-Market Session
Gainers InVivo Therapeutics Hldg (NASDAQ:NVIV) shares rose 11.11% to $1.5 during Friday's after-market session. InVivo ... 
Tags CYCC ATEC AIKI
From Benzinga
Add Up The Pieces: LABU Could Be Worth $93
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
12 Healthcare Stocks Moving In Monday's After-Market Session
Gainers Assertio Holdings (NASDAQ:ASRT) shares surged 7.87% to $0.74 during Monday's after-market session. Today's trading ... 
Tags RGLS Movers GOVX
From Benzinga
44 Stocks Moving In Friday's Mid-Day Session
Gainers Xtant Medical Holdings, Inc. (NYSE: XTNT) jumped 112.1% to $1.74 after the company announced the closing of debt ... 
Tags TARA GERN ADIL
From Benzinga
45 Stocks Moving in Friday's Pre-Market Session
Gainers Lonestar Resources US Inc. (NASDAQ: LONE) shares rose 51.1% to $0.3695 in pre-market trading after gaining over 6% on ... 
Tags FMCI TWLO RNST
From Benzinga
Geron Secures Loan Facility for Up to $75 Million
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that it has entered into a loan facility for up to $75 million with Hercules Capital, Inc. (NYSE:... 
From Business Wire News Releases
Bag This Deal Even Lower Than Director O'farrell Did
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on August 21, Geron Corp.'s Director, Elizabeth G.. 
Tags Stocks
From Market News Video
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Geron Corporation (Nasdaq: GERN) today reported that it has granted a non-statutory stock option to purchase an aggregate of 80,000 shares of Geron common stock as an inducement to a newly-hired... 
From Business Wire News Releases
Geron to Present at the H.C. Wainwright Global Investment Conference
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Chairman and Chief Executive Officer, will present a company overview at... 
From Business Wire News Releases
10 Biggest Price Target Changes For Wednesday
Citigroup boosted salesforce.com, inc. (NYSE: CRM) price target from $196 to $300. salesforce.com shares rose 14.4% to $247.67 in ... 
Tags ADSK GERN CRM
From Benzinga
38 Stocks Moving in Wednesday's Pre-Market Session
Gainers Fluidigm Corporation (NASDAQ: FLDM) shares rose 50.3% to $13.21 in pre-market trading after the company received ... 
Tags KNDI EXPR VIVE
From Benzinga
First Week of October 16th Options Trading For Geron (GERN)
Investors in Geron Corp. (GERN) saw new options become available this week, for the October 16th expiration.. 
Tags Stocks
From Market News Video
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Geron Corporation (Nasdaq: GERN) today reported that it has granted non-statutory stock options to purchase an aggregate of 270,000 shares of Geron common stock as inducements to four newly-hired... 
From Business Wire News Releases
Geron (GERN) Q2 2020 Earnings Call Transcript
GERN earnings call for the period ending June 30, 2020. 
Tags Market News GERN
From Motley Fool
Geron Corporation Reports Second Quarter 2020 Financial Results and Current Events
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today reported financial results for the second quarter ended June 30, 2020. The Company will host a conference call... 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
67 68 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback